Ratio between fms-like Tyrosine Kinase 1 and Placental Growth Factor in Children with Congenital Heart Disease

A modified Glenn shunt reduces venous congestion during acute right ventricular failure due to pulmonary banding: a randomized experimental study

(2014) P. Vikholm et al.   Interactive Cardiovascular and Thoracic Surgery

Hypoxia-Inducible Factor 1 and Cardiovascular Disease

(2013) Gregg L. Semenza   Annual Review of Physiology

Maternal and foetal angiogenic imbalance in congenital heart defects

(2013) E. Llurba et al.   EUROPEAN HEART JOURNAL

An Elevated Ratio of Placental Growth Factor to Soluble Fms-like Tyrosine Kinase-1 Predicts Adverse Outcomes in Patients with Stable Coronary Artery Disease

(2013) Takaki Matsumoto et al.   INTERNAL MEDICINE

Biomarkers of Endothelial Cell Activation in Early Sepsis

(2013) Simon Skibsted et al.   SHOCK

TIMP-2 mutant decreases MMP-2 activity and augments pressure overload induced LV dysfunction and heart failure

(2013) S. Givvimani et al.   ARCHIVES OF PHYSIOLOGY AND BIOCHEMISTRY

Relation of Systemic-to-Pulmonary Artery Collateral Flow in Single Ventricle Physiology to Palliative Stage and Clinical Status

(2012) Ashwin Prakash et al.   AMERICAN JOURNAL OF CARDIOLOGY

Angiogenic Factors and the Risk of Adverse Outcomes in Women With Suspected Preeclampsia

(2012) Sarosh Rana et al.   CIRCULATION

Neurodevelopmental Outcomes in Children With Congenital Heart Disease: Evaluation and Management

(2012) Bradley S. Marino et al.   CIRCULATION

Angiogenic Factors in Superimposed Preeclampsia

(2012) Uma Perni et al.   HYPERTENSION

Volume Overload and Pressure Overload due to Left-to-Right Shunt-Induced Myocardial Injury

(2011) Masaya Sugimoto et al.   CIRCULATION JOURNAL

The Vascular Marker Soluble Fms-Like Tyrosine Kinase 1 Is Associated With Disease Severity and Adverse Outcomes in Chronic Heart Failure

(2011) Bonnie Ky et al.   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY

Elevated Soluble fms-Like Tyrosine Kinase-1 Levels in Acute Coronary Occlusion

(2010) Navin K. Kapur et al.   ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY

Soluble FLT1 sensitizes endothelial cells to inflammatory cytokines by antagonizing VEGF receptor-mediated signalling

(2010) T. Cindrova-Davies et al.   CARDIOVASCULAR RESEARCH

New markers in preeclampsia

(2010) Alexandre Hertig et al.   CLINICA CHIMICA ACTA

Multicenter evaluation of the first automated Elecsys sFlt-1 and PlGF assays in normal pregnancies and preeclampsia

(2010) J. Schiettecatte et al.   CLINICAL BIOCHEMISTRY

Impact of soluble fms-like tyrosine kinase-1 and placental growth factor serum levels for risk stratification and early diagnosis in patients with suspected acute myocardial infarction

(2010) W. Hochholzer et al.   EUROPEAN HEART JOURNAL

Pre-eclampsia: fitting together the placental, immune and cardiovascular pieces

(2010) Joanna L James et al.   JOURNAL OF PATHOLOGY

Soluble fms-Like Tyrosine Kinase 1 (sFlt1), Endoglin and Placental Growth Factor (PlGF) in Preeclampsia among High Risk Pregnancies

(2010) Robert W. Powers et al.   PLoS One

Usefulness of Soluble Fms-like Tyrosine Kinase-1 as a Biomarker of Acute Severe Heart Failure in Patients With Acute Myocardial Infarction

(2009) Kenji Onoue et al.   AMERICAN JOURNAL OF CARDIOLOGY

Short-term delivery of anti-PlGF antibody delays progression of atherosclerotic plaques to vulnerable lesions

(2009) C. Roncal et al.   CARDIOVASCULAR RESEARCH

Reduction of Circulating Soluble Fms-Like Tyrosine Kinase-1 Plays a Significant Role in Renal Dysfunction–Associated Aggravation of Atherosclerosis

(2009) Kenji Onoue et al.   CIRCULATION

Aortopulmonary Collaterals After Bidirectional Cavopulmonary Connection or Fontan Completion

(2009) Lars Grosse-Wortmann et al.   Circulation-Cardiovascular Imaging

High serum levels of procollagen type III N-terminal amino peptide in patients with congenital heart disease

(2009) M Sugimoto et al.   HEART